Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 2:2
Phase 4:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 4
1 (33.3%)Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women
Phase 2
Completed
- Conditions
- Cyclic Breast Pain, Cyclic Mastalgia
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- ASCEND Therapeutics
- Target Recruit Count
- 146
- Registration Number
- NCT00272714
Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80
Phase 2
Completed
- Conditions
- Late Onset HypogonadismHypogonadismLow Testosterone
- Interventions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2022-08-15
- Lead Sponsor
- ASCEND Therapeutics
- Target Recruit Count
- 128
- Registration Number
- NCT00163566
- Locations
- 🇺🇸
Radiant Research - Phoenix, Phoenix, Arizona, United States
🇺🇸Harbor UCLA Medical Reserach and Education Institute, Torrance, California, United States
🇺🇸Malcom Randall VA Medical Center, Gainesville, Florida, United States
Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- ASCEND Therapeutics
- Target Recruit Count
- 221
- Registration Number
- NCT00160173
- Locations
- 🇺🇸
Site 112, Birmingham, Alabama, United States
🇺🇸Site 74, Mobile, Alabama, United States
🇺🇸Site 20, Montgomery, Alabama, United States
News
FDA Approves Generic Estradiol Gel for Postmenopausal Symptom Relief
The FDA has approved a generic estradiol gel, 0.06% (ANI Therapeutics), for treating moderate to severe hot flashes and vaginal changes due to menopause.